For over 22 years pancreatica.org has provided current, credible, and comprehensive information to those in need.
Cancer Patient’s Alliance is a 501(c)(3) non-profit organization. All donations are tax-deductible.

Facebook-f Twitter Envelope Instagram

94% of all revenue goes towards our programs, with only 6% towards MANAGEMENT AND GENERAL EXPENSES.

DONATE TODAY

Author Archives: pancreatica

FOLFIRINOX Dose Modification Study

By pancreatica | Published June 29, 2023

Pancreatic Cancer Blog – Commentary on Articles and AbstractsHere is where we take complex medical articles and break them down into language you and I can understand. Click Here for more Articles and Abstracts. FOLFIRINOX Dose Modification Study6/29/2023CLICK HERE for the original article or abstract ! A recent study titled “Real-world dose reduction of standard and […]

Posted in Pancreatic cancer predated articles | Comments Off on FOLFIRINOX Dose Modification Study

Mitazalimab receives orphan Status for pancreatic cancer

By pancreatica | Published June 1, 2023

Mitazalimab is a monoclonal antibody that targets CD40, a protein that is expressed on the surface of many types of cancer cells. CD40 signaling is thought to play a role in tumor growth and metastasis. Mitazalimab works by blocking CD40 signaling, which can lead to tumor cell death. The FDA has granted orphan drug designation […]

Posted in Pancreatic cancer predated articles | Comments Off on Mitazalimab receives orphan Status for pancreatic cancer

Possible new treatments for pancreatic cancer

By pancreatica | Published June 1, 2023

Scientists have conducted a study, published in the journal Nature, that found pancreatic cancer cells rely on a molecule called uridine for energy when they are deprived of glucose. Uridine is a type of sugar that is not normally used by healthy cells. The researchers found that pancreatic cancer cells have a higher level of […]

Posted in Pancreatic Cancer Stories | Comments Off on Possible new treatments for pancreatic cancer

Early promise for mRNA vaccine that helps program the body to fight pancreatic cancer

By pancreatica | Published May 30, 2023

Studies have found an mRNA vaccine that programs the body to fight pancreatic cancer shows early promise. In a small clinical trial, half of the patients who received the vaccine did not have a recurrence of the tumor a year and a half later. The trial was published in the journal Nature on May 10, […]

Posted in Pancreatic Cancer Stories | Comments Off on Early promise for mRNA vaccine that helps program the body to fight pancreatic cancer

Abraxane and Gemcitabine for Advanced Pancreatic Cancer

By pancreatica | Published May 14, 2020

One of our favorite pancreatic cancer researchers, Dr. Daniel Von Hoff of TGen in Arizona – together with researchers from the Virginia G Piper Cancer Center – is reporting encouraging clinical trials results for those with advanced pancreatic cancer (ductal adenocarcinoma of the pancreas) treated with a combination of Abraxane plus gemcitabine. This MPACT (Metastatic […]

Posted in Pancreatic Cancer Stories | Comments Off on Abraxane and Gemcitabine for Advanced Pancreatic Cancer

© 2024 Pancreatica. All rights reserved | Privacy Policy
312 Fountain Avenue, Pacific Grove, California 93950   |   Phone: (831) 658-0600   |   Fax: (831) 658-0518  |  participate@tofightcancer.com

Facebook-f Twitter Envelope Youtube